International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net
                                                                                                                                                                                                            
Embargo Policy

Responsibilities of the Journals

In order to ensure that there is no unwarranted access to all manuscripts that are submitted to the IJPBS Journal, we follow a strict embargo policy.  The press or public will not have access to the manuscripts until they are published. All possible measures will be taken to make sure that the reviewer honours their promise to confidentiality.IJPBS will not take the responsibility for anybreach of confidentiality either by the reviewer, editorial board member or the corresponding author towards publishing of the manuscript until it gets published in our journal but necessary action will be initiated against that party. For articles published under Green open access or subscription model, an appropriate and sufficient  time is required for the article to have  value to the subscribing or paying customers before an article reaches the stage for free to the public. This period is called an embargo policy . Moreover , this is also to ensure no unwarranted access or displaying of the articles . This also ensures that all possible measures will be taken to make sure that the reviewers honour their promise to confidentiality.  This embargo period begins from the date the article is formally published online in its final and fully citable form. Article published under Green open access has an embargo period of 24 months from the month of publishing in the journal’s respective issue. As articles published under  subscription model remains under subscription until journal releases for open access. Embargo period for this remains until the journal releases for free open access. But Articles published under Gold open access do not have any embargo period.

 

If  a manuscript is released for public access or to the press before its publication  by a breach of confidentiality, the Journal may not publish even an accepted  manuscript.But the manuscript can be presented in the conference or seminars but proper citation or reference should be cited to our journal.We support and encourage discussion of the particular manuscript among the scientists or researcher or news media until embargo period but care should be taken by the author not to reveal complete datas or the complete manuscript or any other activity which hamper our journal citation  of that manuscript or any purported reason of publishing in our journal.If the Journal chooses to make a press release or any other publicity, the information will be given to the authors concerned.  And the details regarding the authors will also be shared with the press personnel or publically displayed. If any litigation or unethical practise made by the author, IJPBS has the right to publish the unethical practise along with the details of the author etc.

 

Responsibilities of the authors

A similar guarantee of confidentiality is expected from the authors also. The author should not release a paper or any part of the paper or the key findings of the study to the press or for public access before publication or after publication (based on the hybrid open access model selected  by the author) and if so, they need to cite that the full paper is under press of our journal. From the time of submission till the time of rejection/publication in case of acceptance, author should avoid sharing the details of the manuscript to public or the press. But if in any case,  any information regarding the manuscript (research findings or the content of the manuscript in part or full) is shared by the author in the form of interview to press or any other form of oral or written communication (in website/forum/blog) it should be withheld from publication until the Press Embargo date. 

If this rule is not adhered to then it will be treated as violation of the Journal’s embargo policy.  These rules of this policy will be in vogue till the embargo is lifted and an “Early version View/forth coming issue listing” is published.

 

The authors can discuss with their peers but should not do this to the extent that complete or part of the unpublished manuscript being published in the media or the public access before the date of full manuscript publishing by our journal.This embargo restriction will be lifted based on the author opted hybrid open access model thereafter the author can post it anywhere but only after due citation requirements are fulfilled.

 

Responsibilities of media and public

The media is expected to follow ethical procedures of the press and refrain from publishing any material before the time for lifting of embargo rules.

 

In case a material is shared to seek expert advice they should still be considered bound by the rules of the Journal’s embargo policy. And any dishonouring even by third parties will be considered an offence.

Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech SolutionsHome I Contact I Terms & Conditions